AUS
NZ
UK
CA
USA
IND
Health
Abbott Labs Pioneering Healthcare Solutions
November 25, 2024 08:15 AM PST| By Team Kalkine MediaHighlight,-Analysts give Abbott Laboratories a "Moderate Buy" rating with a target price of $130.07.,-Recent dividend increase reflects company’s strong financial performance.,-Institutional investors hold 75.18% of Abbott Laboratories' shares.,Abbot...
Henry Schein Stock: Analysts' Current Sentiment
November 25, 2024 04:25 AM PST| By Team Kalkine MediaHighlights:,Henry Schein, Inc. (HSIC) provides health care products and services to a broad range of healthcare professionals.,The company's stock has underperformed the broader market and healthcare sector ETFs in the past year.,Q3 results showed a...
Biogen’s Stock Outlook: Analysts’ Views on Its Future Performance
November 25, 2024 04:20 AM PST| By Team Kalkine MediaHighlights:,Biogen Inc. (BIIB) has underperformed the broader market and key healthcare ETFs in recent years.,The company’s advancements in treatments for Alzheimer’s disease have yet to meet expectations.,Analyst consensus on BIIB remains "Moderate...
Larson Financial Group and Others Expand Stakes in Johnson & Johnson
November 24, 2024 04:59 PM PST| By Team Kalkine MediaHeadlines,Larson Financial Group Increases Stake in Johnson & Johnson,(NYSE:JNJ),Several Institutions Enhance Holdings in Johnson & Johnson (JNJ),Institutional Investors Control Significant Share of Johnson & Johnson Stock,Larson Financial Group LLC...
Artivion Inc.Insider Transactions and What They Might Indicate
November 24, 2024 11:29 AM PST| By Team Kalkine MediaHeadlines,Artivion Executives Reduce Their Holdings,Chairman Sells Portion of Shares Below Current Price,No Insider Purchases Over the Past Year,Over the past year, Artivion Inc.,(NYSE:AORT),insiders have made notable sales of company shares, attract...
Goldman Sachs Identifies Moderna, Inc. (NASDAQ:MRNA) as Key Growth Stock
November 22, 2024 09:15 PM PST| By Team Kalkine MediaHighlights:,Goldman Sachs identifies Moderna as a top growth stock, with a growth investment ratio of 196% and 39 hedge fund holders.,Moderna's significant investments in new vaccines, such as a norovirus treatment, have resulted in increased R&D exp...
_11_22_2024_20_45_39_378797.jpg)
Tenet Healthcare Shows Strong Institutional Interest Amid Market Fluctuations
November 22, 2024 12:44 PM PST| By Team Kalkine MediaHighlights,- Intech increased its stake in Tenet by 44.4%.,- Tenet reported an EPS of $2.93, exceeding expectations.,-Tenet's stock fluctuated between $65.90 and $171.20 over the past year.,Tenet Healthcare Corporation, a key player in the,NYSE Healt...
TG Therapeutics Stock Gains Nearly 15% After Recognition in Deloitte's Fast 500 and Revenue Outlook Enhancement
November 21, 2024 10:07 PM PST| By Team Kalkine MediaHighlights:,TG Therapeutics secures top spot on Deloitte’s Technology Fast 500 list as the fastest-growing biotech company in North America.,Revenue growth driven by the success of BRIUMVI®, its treatment for relapsing multiple sclerosis, with a 230%...
Significant Losses Recorded for Perspective Therapeutics and Pyxis Oncology, Down by 44.33% and 42.93%
November 21, 2024 10:03 PM PST| By Team Kalkine MediaHighlights:,SKK Holdings Limited (SKK) experienced a significant decline of −53.95%.,Perspective Therapeutics, Inc. (CATX) sees a notable drop of −44.33%.,Agrify Corporation (AGFY) faces a decrease of −26.55%, along with other biotech stocks.,SKK Hol...
Modular Medical (Nasdaq: MODD) Secures $8.2 Million in Funding
November 21, 2024 09:29 PM PST| By Team Kalkine MediaHighlights:,Modular Medical secures $8.2 million in funding through public offering.,Strong backing from existing institutional investors, including the largest shareholder.,Offering results in potential dilution for current shareholders at a relativ...
BioXcel Therapeutics (NASDAQ: BTAI) Announces Public Offering to Fund Clinical Trials and Operations
November 21, 2024 09:22 PM PST| By Team Kalkine MediaHighlights:,BioXcel secures funding for clinical trials, including SERENITY and TRANQUILITY.,Effective shelf registration statement in place for the offering.,Potential shareholder dilution and uncertain offering terms may lead to pricing pressure.,B...
Semler Scientific Shares Jump on Thursday: Key Drivers Behind the Rise
November 21, 2024 11:17 AM PST| By Team Kalkine MediaHighlights:,Semler Scientific raises funds through an at-the-market offering, acquiring 215 .,The company now holds a total of 1,273 Bitcoins as part of its strategic treasury initiative.,Semler’s stock has experienced a notable increase following it...
Intuitive Surgical (ISRG) Hits Highest Price in 12 Months
November 21, 2024 11:09 AM PST| By Team Kalkine MediaHighlights:,Intuitive Surgical’s stock reached a new 52-week high, trading at $545.00.,Recent analyst reports have provided varying outlooks, with price targets ranging from $535 to $604.,Insider transactions, including notable sales by executives, h...
Healthcare Stocks Remain Strong with Healthcare Services Group Inc
November 21, 2024 02:36 AM PST| By Team Kalkine MediaHighlights,-Healthcare Services Group offers essential services, ensuring stability in economic downturns.,-Provides consistent demand for healthcare facilities, even in challenging times.,-Faces sector-specific risks that may impact performance.,Hea...
Teleflex Faces Ongoing Decline in Stock Performance
November 21, 2024 12:00 AM PST| By Team Kalkine MediaHighlights,-Teleflex stock declines by 3.4% over the past week.,-Five-year earnings and shareholder returns show consistent downtrend.,-Stock suffers 22% drop over the last three months, continuing recent struggles.,Teleflex Incorporated is a leadin...
Pfizer's Recent Performance: Understanding Long-Term Shareholder Returns
November 20, 2024 11:44 PM PST| By Team Kalkine MediaHeadline,Pfizer's stock has seen a significant drop over the past three years.,Recent declines in earnings per share reveal a challenging period for the company.,Insights from Warren Buffett suggest prices may not fully reflect Pfizer's intrinsic val...
Pyxis Oncology (NASDAQ: PYXS) Announces Positive Phase 1 Trial Data for PYX-201
November 20, 2024 11:11 PM PST| By Team Kalkine MediaHighlights:,50% objective response rate in head and neck cancer patients, including a complete response,26% overall response rate across six solid tumor types,New collaboration with Merck to combine PYX-201 with KEYTRUDA®,Pyxis Oncology (NASDAQ:PYXS)...
Celldex Therapeutics Insider Makes US$308k Share Purchase
November 20, 2024 11:27 AM PST| By Team Kalkine MediaHighlights:,Celldex Therapeutics Founder Anthony Marucci made a significant purchase of company shares, acquiring 40% more stock.,Insider transactions in the past year show a trend of more selling than buying, with the largest sale occurring by the S...
Momentum in Moderna Stock (NASDAQ:MRNA) Fizzled Out
November 20, 2024 10:59 AM PST| By Team Kalkine MediaHighlights:,Moderna’s stock has dropped 71% in the last six months, leading to concerns about its future performance.,Despite potential revenue from emerging infectious diseases, the company’s profitability is uncertain.,The company’s significant cas...
Bruker’s Stock Growth Fueled by CEO’s $5M Acquisition
November 20, 2024 08:05 AM PST| By Team Kalkine MediaHighlights:,Bruker Corporation’s shares saw an increase following CEO Frank Laukien’s purchase of company stock.,Over 1.6 million Bruker shares were traded on the day.,The company operates in the life sciences sector and is listed on NASDAQ under the...
